ATE371455T1 - Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom - Google Patents
Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukomInfo
- Publication number
- ATE371455T1 ATE371455T1 AT02761551T AT02761551T ATE371455T1 AT E371455 T1 ATE371455 T1 AT E371455T1 AT 02761551 T AT02761551 T AT 02761551T AT 02761551 T AT02761551 T AT 02761551T AT E371455 T1 ATE371455 T1 AT E371455T1
- Authority
- AT
- Austria
- Prior art keywords
- glaucoma
- treatment
- retinoprotective
- agents
- feminizing estrogens
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31722501P | 2001-09-05 | 2001-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE371455T1 true ATE371455T1 (de) | 2007-09-15 |
Family
ID=23232682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02761551T ATE371455T1 (de) | 2001-09-05 | 2002-09-03 | Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1423125B1 (de) |
JP (1) | JP2005501888A (de) |
KR (1) | KR100894385B1 (de) |
CN (1) | CN1551773A (de) |
AR (1) | AR038451A1 (de) |
AT (1) | ATE371455T1 (de) |
AU (1) | AU2002326807B2 (de) |
BR (1) | BR0212274A (de) |
CA (1) | CA2458468C (de) |
DE (1) | DE60222143T2 (de) |
ES (1) | ES2289134T3 (de) |
HK (1) | HK1064947A1 (de) |
MX (1) | MXPA04002098A (de) |
PL (1) | PL206249B1 (de) |
TW (1) | TWI320712B (de) |
WO (1) | WO2003020284A1 (de) |
ZA (1) | ZA200401313B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040214806A1 (en) | 2002-09-03 | 2004-10-28 | Iok-Hou Pang | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
CA2527175A1 (en) * | 2003-04-18 | 2004-10-28 | Advanced Medicine Research Institute | Remedies for diseases to be applied to eye |
WO2004093882A1 (ja) * | 2003-04-18 | 2004-11-04 | Advanced Medicine Research Institute | 眼に適用する疾患治療剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2123405C (en) * | 1991-11-22 | 2008-01-15 | Abbot F. Clark | Angiostatic steroids |
US6197833B1 (en) * | 1995-07-24 | 2001-03-06 | Apollo Biopharmaceutics, Inc. | Neuroprotective effects of polycyclic phenolic compounds |
US5521168A (en) * | 1994-10-13 | 1996-05-28 | Alcon Laboratories, Inc. | Estrogen metabolites for lowering intraocular pressure |
WO2002042319A2 (en) * | 2000-11-27 | 2002-05-30 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
-
2002
- 2002-08-21 TW TW091118916A patent/TWI320712B/zh not_active IP Right Cessation
- 2002-08-29 AR ARP020103261A patent/AR038451A1/es unknown
- 2002-09-03 KR KR1020047003273A patent/KR100894385B1/ko not_active IP Right Cessation
- 2002-09-03 ES ES02761551T patent/ES2289134T3/es not_active Expired - Lifetime
- 2002-09-03 AT AT02761551T patent/ATE371455T1/de not_active IP Right Cessation
- 2002-09-03 WO PCT/US2002/027969 patent/WO2003020284A1/en active IP Right Grant
- 2002-09-03 CN CNA028173740A patent/CN1551773A/zh active Pending
- 2002-09-03 MX MXPA04002098A patent/MXPA04002098A/es active IP Right Grant
- 2002-09-03 BR BR0212274-0A patent/BR0212274A/pt not_active Application Discontinuation
- 2002-09-03 CA CA2458468A patent/CA2458468C/en not_active Expired - Fee Related
- 2002-09-03 AU AU2002326807A patent/AU2002326807B2/en not_active Ceased
- 2002-09-03 PL PL374243A patent/PL206249B1/pl not_active IP Right Cessation
- 2002-09-03 DE DE60222143T patent/DE60222143T2/de not_active Expired - Lifetime
- 2002-09-03 EP EP02761551A patent/EP1423125B1/de not_active Expired - Lifetime
- 2002-09-03 JP JP2003524591A patent/JP2005501888A/ja active Pending
-
2004
- 2004-02-18 ZA ZA200401313A patent/ZA200401313B/en unknown
- 2004-10-11 HK HK04107793A patent/HK1064947A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1423125B1 (de) | 2007-08-29 |
EP1423125A4 (de) | 2005-02-09 |
AU2002326807B2 (en) | 2007-08-23 |
CA2458468A1 (en) | 2003-03-13 |
AR038451A1 (es) | 2005-01-19 |
TWI320712B (en) | 2010-02-21 |
KR100894385B1 (ko) | 2009-04-22 |
CA2458468C (en) | 2010-08-24 |
KR20040033012A (ko) | 2004-04-17 |
ES2289134T3 (es) | 2008-02-01 |
EP1423125A1 (de) | 2004-06-02 |
BR0212274A (pt) | 2004-10-19 |
WO2003020284A1 (en) | 2003-03-13 |
PL206249B1 (pl) | 2010-07-30 |
DE60222143T2 (de) | 2008-06-05 |
JP2005501888A (ja) | 2005-01-20 |
ZA200401313B (en) | 2005-05-11 |
MXPA04002098A (es) | 2004-06-07 |
CN1551773A (zh) | 2004-12-01 |
PL374243A1 (en) | 2005-10-03 |
DE60222143D1 (de) | 2007-10-11 |
HK1064947A1 (en) | 2005-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
ATE358669T1 (de) | Pyrazolderivate zur behandlung von hiv | |
ATE451921T1 (de) | Phenylindole zur behandlung von hiv | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
DE60218451D1 (de) | 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation | |
DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
DE60103685D1 (de) | Behandlung von Poriomania | |
DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
DE50212649D1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
ATE443060T1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
ATE371455T1 (de) | Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom | |
DE60120961D1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen | |
DE60105053D1 (de) | Zusammensetzungen zur behandlung von gewebe | |
ATE343387T1 (de) | S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen. | |
DE60103071D1 (de) | Behandlung von flüssigkeiten | |
ATE226440T1 (de) | Zusammensetzung zur behandlung von psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |